Drug
Nelfinavir
Nelfinavir: highest development phase Phase 1, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nelfinavir mesylate NCT00002380 | Phase 1 | HIV Infections |
Latest
No recent events.
Follow Nelfinavir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.